Free Trial

Biotricity (BTCY) Competitors

Biotricity logo
$0.50 +0.00 (+0.16%)
As of 07/24/2025 12:50 PM Eastern

BTCY vs. MLSS, NMTC, DXR, TMDIF, PYPD, MODD, NEPH, POCI, COCH, and VVOS

Should you be buying Biotricity stock or one of its competitors? The main competitors of Biotricity include Milestone Scientific (MLSS), NeuroOne Medical Technologies (NMTC), Daxor (DXR), Titan Medical (TMDIF), PolyPid (PYPD), Modular Medical (MODD), Nephros (NEPH), Precision Optics (POCI), Envoy Medical (COCH), and Vivos Therapeutics (VVOS). These companies are all part of the "medical equipment" industry.

Biotricity vs. Its Competitors

Milestone Scientific (NYSE:MLSS) and Biotricity (NASDAQ:BTCY) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

Milestone Scientific has a net margin of -52.01% compared to Biotricity's net margin of -80.42%. Biotricity's return on equity of 0.00% beat Milestone Scientific's return on equity.

Company Net Margins Return on Equity Return on Assets
Milestone Scientific-52.01% -60.26% -40.23%
Biotricity -80.42%N/A -188.47%

5.8% of Milestone Scientific shares are held by institutional investors. Comparatively, 3.9% of Biotricity shares are held by institutional investors. 24.8% of Milestone Scientific shares are held by insiders. Comparatively, 10.1% of Biotricity shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Milestone Scientific has higher earnings, but lower revenue than Biotricity. Milestone Scientific is trading at a lower price-to-earnings ratio than Biotricity, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Milestone Scientific$8.61M5.42-$6.93M-$0.07-8.50
Biotricity$12.06M1.03-$14.09M-$0.67-0.75

Milestone Scientific has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, Biotricity has a beta of 1.11, indicating that its share price is 11% more volatile than the S&P 500.

Milestone Scientific presently has a consensus target price of $1.25, suggesting a potential upside of 110.08%. Given Milestone Scientific's stronger consensus rating and higher probable upside, research analysts clearly believe Milestone Scientific is more favorable than Biotricity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Milestone Scientific
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00
Biotricity
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Biotricity had 8 more articles in the media than Milestone Scientific. MarketBeat recorded 9 mentions for Biotricity and 1 mentions for Milestone Scientific. Biotricity's average media sentiment score of 0.70 beat Milestone Scientific's score of -1.00 indicating that Biotricity is being referred to more favorably in the news media.

Company Overall Sentiment
Milestone Scientific Negative
Biotricity Positive

Summary

Milestone Scientific beats Biotricity on 10 of the 16 factors compared between the two stocks.

Get Biotricity News Delivered to You Automatically

Sign up to receive the latest news and ratings for BTCY and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BTCY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BTCY vs. The Competition

MetricBiotricitySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$12.45M$66.20M$5.73B$9.47B
Dividend YieldN/AN/A4.60%3.99%
P/E Ratio-0.466.0527.9819.95
Price / Sales1.03142.51447.46100.93
Price / CashN/A18.4136.5558.97
Price / Book-0.387.348.655.90
Net Income-$14.09M-$25.32M$3.24B$258.42M
7 Day Performance14.84%1.35%3.69%2.11%
1 Month Performance31.53%4.16%10.34%12.44%
1 Year Performance-35.06%53.27%34.36%19.55%

Biotricity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BTCY
Biotricity
N/A$0.50
+0.2%
N/A-34.7%$12.45M$12.06M-0.4640Analyst Revision
Gap Down
MLSS
Milestone Scientific
2.9548 of 5 stars
$0.64
+1.7%
$1.25
+94.9%
-38.7%$50.32M$8.61M-9.1630
NMTC
NeuroOne Medical Technologies
3.0373 of 5 stars
$1.03
+14.4%
$1.45
+40.8%
+11.1%$44.84M$3.45M-4.6820High Trading Volume
DXR
Daxor
3.4473 of 5 stars
$9.18
+2.0%
$25.00
+172.3%
+5.8%$44.42M$2.13M0.0037
TMDIF
Titan Medical
N/A$0.38
+2.8%
N/A+979.5%$43.37M$17.63M-0.3050Gap Up
PYPD
PolyPid
3.1518 of 5 stars
$3.76
+0.3%
$11.80
+213.8%
+7.2%$38.22MN/A-0.8780Positive News
MODD
Modular Medical
1.0547 of 5 stars
$0.70
+0.1%
N/A-54.8%$37.92MN/A-1.3720Gap Up
NEPH
Nephros
2.4008 of 5 stars
$3.51
-1.7%
$5.00
+42.5%
+56.4%$37.84M$14.16M50.1530
POCI
Precision Optics
0.1959 of 5 stars
$4.80
-1.2%
N/A-22.8%$37.26M$19.10M-5.3980
COCH
Envoy Medical
2.2351 of 5 stars
$1.61
flat
$9.25
+474.5%
-24.9%$34.34M$220K-1.1734
VVOS
Vivos Therapeutics
0.8854 of 5 stars
$5.50
+1.1%
$4.82
-12.4%
+122.1%$32.04M$14.63M-3.18160Positive News

Related Companies and Tools


This page (NASDAQ:BTCY) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners